[시장보고서]세계의 유전자 편집 및 CRISPR 진단 시장 : 용도별, 기술별, 장소별, 업계별, 제품별, 이그제큐티브 컨설턴트 가이드 첨부(2026-2030년)

세계의 유전자 편집 및 CRISPR 진단 시장 : 용도별, 기술별, 장소별, 업계별, 제품별, 이그제큐티브 컨설턴트 가이드 첨부(2026-2030년)

Gene Editing & CRISPR Diagnostic Markets. By Application, Technology, Place, Industry & Product with Executive and Consultant Guides. 2026 to 2030

상품코드 : 1826002

리서치사 : Howe Sound Research

발행일 : 2025년 09월

페이지 정보 : 영문 465 Pages

라이선스 & 가격 (부가세 별도)

US $ 6,995

￦ 10,099,000

PDF (Single User License)

PDF 보고서를 1명(One device)만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,495

￦ 15,152,000

PDF (Five User License)

PDF 보고서를 동일 사업장의 5명(Five devices)까지 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 13,995

￦ 20,205,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

보고서 개요

유전자 편집은 힘을 증가하고 있습니다. CRISPR과 유사한 도구는 생명 공학의 모든 분야에서 새로운 용도를 찾습니다. 그것은 살아있는 인간 세포의 유전자를 변화시켜 의료에 적용하는 것으로 시작됩니다. 불치의 질병은 이미 치유되었습니다. 더 많은 질병이 진행 중입니다. 급성장 노선이 가속되고 있습니다. 여러 산업에서 새로운 용도가 개발되고 있습니다. 기술의 비약적 진보 때마다 새로운 기회가 탄생하고 있습니다. 다양한 기회를 이해합니다. 단기적, 장기적으로 무엇이 예상되는지 알 수 있습니다. 현실적인 성장 예측을 파악합니다. 당사의 조사를 통해 귀사는 조직의 전문가가 됩니다.

요청에 따라 모든 보고서 데이터를 엑셀 형식으로 제공합니다.

시장 구조치료제
- 연구개발(R&D)기업
- 바이오테크놀러지 기업
- 제네릭 의약품 제조업체
- 주요 제약 회사
- 계약연구기관(CRO)
- 계약제조조직(CMO)
- 전문의약품회사
- 의약품 판매업자
- 소매 약국
- 도매업체
- 온라인 약국
- 의료기술기업
- 약국 혜택 관리자(PBM)
- 임상 실험실
- 의료기기 기업
- 규제기관
시장 구조진단
- 학술연구기관
- 진단 시험 개발자
- 계측기기 공급자
- 약품 및 시약 제조업체
- 병리 공급자
- 독립계 임상 실험실
- 공공의 국립/지역 연구소
- 병원 검사실
- 임상 실험실
- 감사기관
- 인증기관

제4장 시장 동향

성장 촉진요인
성장 억제요인

제5장 유전자 편집의 최근 동향

제6장 주요 기업

주요 기업 - 본 장의 중요성과 사용법
10x Genomics, Inc.
4D Molecular Therapeutics
Abeona Therapeutics
Acrigen Biosciences
Adarx Pharmaceuticals
Adverum Biotechnologies
Affini-T Therapeutics
Agilent
Arbor Biotechnologies
Arcturus Therapeutics
Axxam
Beam Therapeutics
Beckman Coulter Diagnostics(Danaher)
Becton, Dickinson and Company
Binx Health
bioMerieux Diagnostics
Bio-Rad Laboratories, Inc
Bluebird Bio
Caribou Biosciences
Cell Microsystems
Cellenion(BICO)
Century Therapeutics
Chroma Medicine
Creative Biogene
Crispr Therapeutics
Editas Medicine
ERS Genomics
FASMAC
Genscript Biotech
Illumina
Inscripta
Intellia Therapeutics
J&J Innovative Medicine
Locus Biosciences
Mammoth Biosciences
Metagenomi
Myllia Biotechnology
Namocell
NRGene
Oxford Biomedica
Poseida Therapeutics
Precision Biosciences
Prime Medicine
Proof Diagnostics
Regeneron Pharmaceuticals
Revvity
Roche Diagnostics
Sangamo Therapeutics
Sherlock Biosciences
Thermo Fisher Scientific
Twist Bioscience
VedaBio
Verve Therapeutics
Vivlion
Wave Life Science

제7장 세계의 유전자 편집 시장

국가별 세계 시장 개요
용도별 세계 시장 - 개요
기술별 세계 시장 - 개요
장소별 세계 시장 - 개요
업계별 세계 시장 - 개요
제품별 세계 시장 - 개요

제8장 유전자 편집 시장- 용도별

세포주
식물
동물
세포요법
유전자 치료
진단
연구
기타

제9장 세계의 유전자 편집 시장 - 기술별

CRISPR
Talens
ZFN
메가뉴클레아제
기타

제10장 유전자 편집 시장- 장소별

생체내
생체외
체외

제11장 유전자 편집 시장 - 업계별

제약
임상
학술
수탁기관
기타

제12장 세계의 유전자 편집 시장- 제품별

기기
세포
시약
기타

제13장 부록

JHS

영문 목차

영문목차

Report Overview:

Gene Editing is moving from strength to strength. CRISPR and similar tools are finding new uses in every area of biotechnology. It started with Medical applications by changing genes in living human cells. Uncurable diseases have already being cured. More are on the way. A fast growth path is accelerating. New applications are developing in multiple industries. New opportunities are arising with every technological breakthrough. Understand the various opportunities. Find out what is expected in the near term and the long term. Get a handle on realistic growth expectations. Our research makes you the expert in your organization.

All report data is available in Excel format on request.

1. Market Guides

1.1. Strategic Situation Analysis
1.2. Guide for Executives, Marketing, Sales and Business Development Staff
1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

2.1. Methodology
- 2.1.1. Methodology
- 2.1.2. Sources
- 2.1.3. Authors
2.2. What is Gene Editing?
2.3. The CRISPR Example
- 2.3.1. What is CRISPR?
- 2.3.2. The CRISPR Family
2.4. Chromosomes, Genes and Epigenetics
- 2.4.1. Chromosomes
- 2.4.2. Genes
- 2.4.3. Epigenetics
2.5. Market Definition
- 2.5.1. Revenue Market Size
2.6. Perspective: Healthcare Spending
- 2.6.1. Global Healthcare Spending
- 2.6.2. Spending on Healthcare and Pharmaceuticals
- 2.6.3. Spending on Diagnostics
- 2.6.4. Important Role of Insurance for Medical Services

3. Market Structure

3.1. Market Structure Therapeutics
- 3.1.1. Research and Development (R&D) Companies
- 3.1.2. Biotechnology Companies
- 3.1.3. Generic Drug Manufacturers
- 3.1.4. Big Pharmaceuticals
- 3.1.5. Contract Research Organizations (CROs)
- 3.1.6. Contract Manufacturing Organizations (CMOs)
- 3.1.7. Specialty Pharmaceutical Companies
- 3.1.8. Pharmaceutical Distributors
- 3.1.9. Retail Pharmacies
- 3.1.10. Wholesalers
- 3.1.11. Online Pharmacies
- 3.1.12. Health Technology Companies
- 3.1.13. Pharmacy Benefit Managers (PBMs)
- 3.1.14. Clinical Laboratories
- 3.1.15. Medical Device Companies
- 3.1.16. Regulatory Bodies
3.2. Market Structure Diagnostics
- 3.2.1. Academic Research Lab
- 3.2.2. Diagnostic Test Developer
- 3.2.3. Instrumentation Supplier
- 3.2.4. Chemical/Reagent Supplier
- 3.2.5. Pathology Supplier
- 3.2.6. Independent Clinical Laboratory
- 3.2.7. Public National/regional Laboratory
- 3.2.8. Hospital Laboratory
- 3.2.9. Physicians Office Lab (POLS)
- 3.2.10. Audit Body
- 3.2.11. Certification Body

4. Market Trends

4.1. Factors Driving Growth
- 4.1.1. Cell Therapy
- 4.1.2. Gene Therapy
- 4.1.3. The New Agriculture
- 4.1.4. Genetics and Cell Metabolism
4.2. Factors Limiting Growth
- 4.2.1. The Cost Curve
- 4.2.2. Time and Trials
- 4.2.3. The Price Barrier

5. Recent Developments in Gene Editing

5.1. Recent Developments - Importance and How to Use This Section
- 5.1.1. Importance of These Developments
- 5.1.2. How to Use This Section
5.2. VedaBio Licenses Diagnostic CRISPR Technology
5.3. YolTech Therapeutics Raises $45 Million in Series B Funding
5.4. Prime Editing Breakthrough Corrects Genetic Deficiency
5.5. Arbor Biotechnologies Announces First Patient Dosed
5.6. CRISPR Therapeutics Reports Positive Data for Liver-Targeted Therapy
5.7. Lilly to acquire Verve Therapeutics
5.8. Personalized CRISPR Therapy for Infant with Rare Genetic Disease
5.9. New CRISPR Diagnostic Test Detects Pathogens Without Amplification
5.10. OraSure Technologies Acquires Sherlock Biosciences
5.11. CRISPR tool allows for remote-controlled gene-editing
5.12. CRISPR Making Sweeter Tomatoes
5.13. Researchers Create gene-edited prawns
5.14. Gene Editing Corrects Cystic Fibrosis
5.15. Gene Editing Reverses Heart Disease In Mice
5.16. CRISPR gene editing to change healthcare?
5.17. CrisprBits Collaborates With MolBio Diagnostics
5.18. Sherlock Bioscience to Launch Free AI-Based Operating System
5.19. Sherlock Biosciences to Acquire Sense Biodetection
5.20. CRISPR Enzyme Discovery Opens New Applications
5.21. Sherlock Biosciences Adds Ambient Amplification to Toolkit
5.22. Rice University Adapts CRISPR Enzyme
5.23. Princeton Group Develops Cas13 Assay for Point-of-Care Use
5.24. Proof Dx Plans Infectious Disease, Oncology Tests for CRISPR-Based POC System
5.25. Sherlock Biosciences Raises $80M
5.26. Broad Institute Considers CRISPR Respiratory Panels to Replace PCR
5.27. Medix Biochemica Acquires MyPols Biotec
5.28. Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets EUA

6. Key Companies

6.1. Key Companies - Importance and How to Use This Section
- 6.1.1. Importance of These Players
- 6.1.2. How to Use This Section
6.2. 10x Genomics, Inc.
6.3. 4D Molecular Therapeutics
6.4. Abeona Therapeutics
6.5. Acrigen Biosciences
6.6. Adarx Pharmaceuticals
6.7. Adverum Biotechnologies
6.8. Affini-T Therapeutics
6.9. Agilent
6.10. Arbor Biotechnologies
6.11. Arcturus Therapeutics
6.12. Axxam
6.13. Beam Therapeutics
6.14. Beckman Coulter Diagnostics (Danaher)
6.15. Becton, Dickinson and Company
6.16. Binx Health
6.17. bioMerieux Diagnostics
6.18. Bio-Rad Laboratories, Inc
6.19. Bluebird Bio
6.20. Caribou Biosciences
6.21. Cell Microsystems
6.22. Cellenion (BICO)
6.23. Century Therapeutics
6.24. Chroma Medicine
6.25. Creative Biogene
6.26. Crispr Therapeutics
6.27. Editas Medicine
6.28. ERS Genomics
6.29. FASMAC
6.30. Genscript Biotech
6.31. Illumina
6.32. Inscripta
6.33. Intellia Therapeutics
6.34. J&J Innovative Medicine
6.35. Locus Biosciences
6.36. Mammoth Biosciences
6.37. Metagenomi
6.38. Myllia Biotechnology
6.39. Namocell
6.40. NRGene
6.41. Oxford Biomedica
6.42. Poseida Therapeutics
6.43. Precision Biosciences
6.44. Prime Medicine
6.45. Proof Diagnostics
6.46. Regeneron Pharmaceuticals
6.47. Revvity
6.48. Roche Diagnostics
6.49. Sangamo Therapeutics
6.50. Sherlock Biosciences
6.51. Thermo Fisher Scientific
6.52. Twist Bioscience
6.53. VedaBio
6.54. Verve Therapeutics
6.55. Vivlion
6.56. Wave Life Science

7. The Global Market for Gene Editing

7.1. Global Market Overview by Country
- 7.1.1. Table - Global Market by Country
- 7.1.2. Chart - Global Market by Country
7.2. Global Market by Application - Overview
- 7.2.1. Table - Global Market by Application
- 7.2.2. Chart - Global Market by Application - Base/Final Year Comparison
- 7.2.3. Chart - Global Market by Application - Base Year
- 7.2.4. Chart - Global Market by Application - Final Year
- 7.2.5. Chart - Global Market by Application - Share by Year
- 7.2.6. Chart - Global Market by Application - Segment Growth
7.3. Global Market Technology - Overview
- 7.3.1. Table - Global Market by Technology
- 7.3.2. Chart - Global Market by Technology - Base/Final Year Comparison
- 7.3.3. Chart - Global Market by Technology - Base Year
- 7.3.4. Chart - Global Market by Technology - Final Year
- 7.3.5. Chart - Global Market by Technology - Share by Year
- 7.3.6. Chart - Global Market by Technology - Segment Growth
7.4. Global Market Type - Overview
- 7.4.1. Table - Global Market by Type
- 7.4.2. Chart - Global Market by Type - Base/Final Year Comparison
- 7.4.3. Chart - Global Market by Type - Base Year
- 7.4.4. Chart - Global Market by Type - Final Year
- 7.4.5. Chart - Global Market by Type - Share by Year
- 7.4.6. Chart - Global Market by Type - Segment Growth
7.5. Global Market Industry - Overview
- 7.5.1. Table - Global Market by Industry
- 7.5.2. Chart - Global Market by Industry - Base/Final Year Comparison
- 7.5.3. Chart - Global Market by Industry - Base Year
- 7.5.4. Chart - Global Market by Industry - Final Year
- 7.5.5. Chart - Global Market by Industry - Share by Year
- 7.5.6. Chart - Global Market by Industry - Segment Growth
7.6. Global Market Product - Overview
- 7.6.1. Table - Global Market by Product
- 7.6.2. Chart - Global Market by Product - Base/Final Year Comparison
- 7.6.3. Chart - Global Market by Product - Base Year
- 7.6.4. Chart - Global Market by Product - Final Year
- 7.6.5. Chart - Global Market by Product - Share by Year
- 7.6.6. Chart - Global Market by Product - Segment Growth

8. Gene Editing Markets - By Application

8.1. Cell Line
- 8.1.1. Table Cell Line - by Country
- 8.1.2. Chart - Cell Line Growth
8.2. Plant
- 8.2.1. Table Plant - by Country
- 8.2.2. Chart - Plant Growth
8.3. Animal
- 8.3.1. Table Animal - by Country
- 8.3.2. Chart - Animal Growth
8.4. Celll Therapy
- 8.4.1. Table Cell Therapy - by Country
- 8.4.2. Chart - Cell Therapy Growth
8.5. Gene Therapy
- 8.5.1. Table Gene Therapy - by Country
- 8.5.2. Chart - Gene Therapy Growth
8.6. Diagnostics
- 8.6.1. Table Diagnostics - by Country
- 8.6.2. Chart - Diagnostics Growth
8.7. Research
- 8.7.1. Table Research - by Country
- 8.7.2. Chart - Research Growth
8.8. Other Application
- 8.8.1. Table Other Application - by Country
- 8.8.2. Chart - Other Application Growth

9. Global Gene Editing Markets - by Technology

9.1. Crispr
- 9.1.1. Table Crispr - by Country
- 9.1.2. Chart - Crispr Growth
9.2. Talens
- 9.2.1. Table Talens - by Country
- 9.2.2. Chart - Talens Growth
9.3. ZFN
- 9.3.1. Table ZFN - by Country
- 9.3.2. Chart - ZFN Growth
9.4. Meganuclease
- 9.4.1. Table Meganuclease - by Country
- 9.4.2. Chart - Meganuclease Growth
9.5. Other Technology
- 9.5.1. Table Other Technology - by Country
- 9.5.2. Chart - Other Technology Growth

10. Gene Editing Markets - by Place

10.1. In Vivo
- 10.1.1. Table In Vivo - by Country
- 10.1.2. Chart - In Vivo Growth
10.2. Ex Vivo
- 10.2.1. Table Ex Vivo - by Country
- 10.2.2. Chart - Ex Vivo Growth
10.3. In Vitro
- 10.3.1. Table In Vitro - by Country
- 10.3.2. Chart - In Vitro Growth

11. Gene Editing Markets - by Industry

11.1. Pharma
- 11.1.1. Table Pharma - by Country
- 11.1.2. Chart - Pharma Growth
11.2. Clinical
- 11.2.1. Table Clinical - by Country
- 11.2.2. Chart - Clinical Growth
11.3. Academic
- 11.3.1. Table Academic - by Country
- 11.3.2. Chart - Academic Growth
11.4. Contract
- 11.4.1. Table Contract - by Country
- 11.4.2. Chart - Contract Growth
11.5. Other Industry
- 11.5.1. Table Other Industry - by Country
- 11.5.2. Chart - Other Industry Growth

12. Global Gene Editing Markets - by Product

12.1. Instruments
- 12.1.1. Table Instruments - by Country
- 12.1.2. Chart - Instruments Growth
12.2. Cells
- 12.2.1. Table Cells - by Country
- 12.2.2. Chart - Cells Growth
12.3. Reagents
- 12.3.1. Table Reagents - by Country
- 12.3.2. Chart - Reagents Growth
12.4. Other Product
- 12.4.1. Table Other Product - by Country
- 12.4.2. Chart - Other Product Growth

13. Appendices

13.1. United States Medicare System: laboratory Fees Schedule
13.2. The Most Used IVD Assays
13.3. The Highest Grossing Assays
13.4. Global Listing of Sequencing Establishments - Location & Contacts